The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer

• by Frederik R. Teunissen, Thomas Willigenburg, Richard P. Meijer, Harm H. E. van Melick, Helena M. Verkooijen, Jochem R. N. van der Voort van Zyp

• July 21, 2022

Adjuvant vs Salvage Radiation Therapy for Prostate Cancer: New Data

Dr. Jessica Karen Wong presents a discussion on Adjuvant vs Salvage Radiation Therapy for Prostate Cancer: New Data.

• July 19, 2021

• 1 min

More Than 145 Dana-Farber Affiliated Faculty Named as 2026 Top Doctors™ in Boston Magazine

Boston magazine has named more than 145 physicians affiliated with Dana-Farber Cancer Institute to its annual "Top Doctors" guide. Drawing from a Castle Connolly Medical Ltd. physician database, the Boston magazine Top Doctors™ list draws from hundreds of Boston-area physicians in many medical specialties

• by

• January 27, 2026

• 6 min

Precision Oncology in Practice: How Theranostics Personalizes Treatment

In precision oncology, theranostics stands out as a transformative approach that tailors cancer treatment to the unique molecular profile of each patient. By integrating advanced diagnostic imaging with targeted therapy, theranostics ensures that treatments are customized to the unique characteristics of each patient's cancer, thereby optimizing efficacy and minimizing adverse effects.

• by

• May 11, 2025

• 4 min